Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |